AIMD News and Press, Ainos Inc From 05/07/24

Proceeds for scaling up the company's VELDONA and AI Nose growth initiatives Convertible note convertible at $4.5 per share placed with existing shareholder SAN DIEGO, CA / ACCESSWIRE / May 7, 2024 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos", or the "Company"), a diversified hea...

2024-04-08 16:28:51 ET More on Ainos Ainos announces $1.75M follow-on funding Financial information for Ainos Read the full article on Seeking Alpha For further details see: Ainos files to sell 4.43M common shares for holders

2024-03-11 10:00:56 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...

2024-03-11 08:26:10 ET More on pre-market losers & stocks. Mizuho Financial: Still In The Early Stages Of Its Re-Rating Path Mizuho Financial: Multiple Re-Rating Catalysts (Rating Upgrade) RIOT, MARA among week's biggest financial losers despite bitcoin rally ...

2024-03-11 06:20:00 ET 3 Data Types to Use for Buying Penny Stocks Trading penny stocks offers a unique opportunity for investors looking to diversify their portfolios with potentially high-return investments. Understanding the nuances of the market and leveraging the right data types a...

2024-03-09 07:04:00 ET 3 Ways That Elections Impact the Price of Penny Stocks in 2024 Elections hold significant sway over financial markets, influencing investor sentiment and market trends. Penny stocks, known for their potential for high returns, are no exception. Understanding how e...

2024-03-08 16:30:59 ET More on Ainos Ainos announces $1.75M follow-on funding Ainos regains compliance with Nasdaq minimum bid price rule Financial information for Ainos Read the full article on Seeking Alpha For further details see: Ainos GAAP EP...

Strategic pivot towards VELDONA and AI-powered point-of-care testing to continue in 2024 Advancing VELDONA drug candidates to Phase III clinical studies Expanding market of AI Nose-powered VOC-sensing technology with strategic partners NISD and Inabata SAN DIEGO, CA / ACCESSWIRE / M...

2024-03-08 10:00:23 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...

2024-03-08 08:30:06 ET Ainos ( AIMD ) +147% . Psyence Biomedical ( PBM ) +104% . CERo Therapeutics ( CERO ) +47% . Gulf Island Fabrication ( GIFI ) +27% on Q4 earnings release . Recruiter.com ( RCRT ) +17% . Porch Group ( P...